SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001047469-12-001293
Filing Date
2012-02-22
Accepted
2012-02-22 16:14:57
Documents
14
Period of Report
2011-12-31

Document Format Files

Seq Description Document Type Size
1 10-K a2207399z10-k.htm 10-K 1805619
2 EX-21.1 a2207399zex-21_1.htm EX-21.1 106114
3 EX-23.1 a2207399zex-23_1.htm EX-23.1 3509
4 EX-31.1 a2207399zex-31_1.htm EX-31.1 8059
5 EX-31.2 a2207399zex-31_2.htm EX-31.2 8114
6 EX-32.1 a2207399zex-32_1.htm EX-32.1 4394
7 EX-32.2 a2207399zex-32_2.htm EX-32.2 4438
14 G450919.JPG g450919.jpg GRAPHIC 39680
  Complete submission text file 0001047469-12-001293.txt   16568745

Data Files

Seq Description Document Type Size
8 EX-101.INS celg-20111231.xml EX-101.INS 2255747
9 EX-101.SCH celg-20111231.xsd EX-101.SCH 137999
10 EX-101.CAL celg-20111231_cal.xml EX-101.CAL 168418
11 EX-101.LAB celg-20111231_lab.xml EX-101.LAB 2286361
12 EX-101.PRE celg-20111231_pre.xml EX-101.PRE 998940
13 EX-101.DEF celg-20111231_def.xml EX-101.DEF 681633
Mailing Address 86 MORRIS AVENUE SUMMIT NJ 07901
Business Address 86 MORRIS AVENUE SUMMIT NJ 07901 (908)673-9000
CELGENE CORP /DE/ (Filer) CIK: 0000816284 (see all company filings)

IRS No.: 222711928 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-34912 | Film No.: 12630452
SIC: 2834 Pharmaceutical Preparations